← Back
$STOK All transactions

Stoke Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$1.3M

Shares

33,243

Price

$40

Filed

Mar 12

Insider

Name

Krainer Adrian R.

Title

CIK

0001780081

Roles

Director

Transaction Details

Transaction Date

2026-03-10

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

283,302

Footnotes

The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2025. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.50 to $40.11 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Filing Info

Accession No.

0001780081-26-000004

Form Type

4

Issuer CIK

0001623526

Krainer Adrian R.'s History

Date Ticker Type Value
2026-03-10 STOK $1.3M
2026-03-02 STOK $287K
2025-11-24 STOK $1.2M
2025-11-14 STOK $527K
2025-11-14 STOK $565K
2025-06-03 STOK A $0

Other Insiders at STOK (90d)

Insider Bought Sold Last
LEVIN ARTHUR A $22K 2026-03-13
SMITH IAN F
Chief Executive Officer
2026-02-17
Kaye Edward M. MD 2026-03-15
TZIANABOS ARTHUR
Interim Executive Chair
$174K 2026-03-10
Hoitt Jason
Chief Patient Officer
$119K 2026-03-18
Leggett Thomas
Chief Financial Officer
$147K 2026-03-18
Krainer Adrian R. $287K 2026-03-02
Ticho Barry
CHIEF MEDICAL OFFICER
$517K 2026-04-01
Kahn Clare 2026-04-03
Allan Jonathan
GENERAL COUNSEL & CORP SEC
$599K 2026-03-20